Erythromycin Tablet, Delayed Release
Product Images NDC 69238-1471

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 69238-1471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Erythromycin Delayed Release Tablets Usp 1)

Chemical structure of erythromycin, a macrolide antibiotic. The diagram shows the molecular arrangement of atoms and bonds characteristic of erythromycin's chemical composition.*

FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 2)

Erythromycin Delayed-Release Tablets USP 250 mg oral tablets packaging label by Amneal Pharmaceuticals NY LLC. The label states the delayed-release formulation with a quantity of 30 tablets. It includes storage instructions, dosage note, manufacturer information from Amneal Pharmaceuticals Pvt. Ltd., India, and distributor details in New Jersey. The label features a barcode and emphasizes not to accept if the seal is broken or missing.*

FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 3)

Label for Erythromycin Delayed-Release Tablets USP 250 mg by Amneal Pharmaceuticals. This prescription oral tablet is supplied in a 100 count bottle. The label contains dosage storage instructions, manufacturer information in India, distributor information in New Jersey, and a barcode.*

FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 4)

Label for Erythromycin Delayed-Release Tablets, USP 333 mg by Amneal Pharmaceuticals NY LLC. The label specifies dosage form as delayed-release oral tablets, with a pack count of 30 tablets. It includes storage instructions and manufacturer details, with a barcode on the right side.*

FDA Label Image

Erythromycin Delayed Release Tablets Usp 5

Label for Erythromycin Delayed-Release Tablets USP, 333 mg strength. The label indicates the product is oral tablets, distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ, and manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India. The package contains 100 tablets. Includes storage instructions, barcode, and warning about seal integrity.*

FDA Label Image

Erythromycin Delayed Release Tablets Usp 6

Erythromycin Delayed-Release Tablets, USP 500 mg oral tablets label by Amneal Pharmaceuticals NY LLC. The label includes prescription status (Rx only), quantity (30 tablets), storage instructions, manufacturer Amneal Pharmaceuticals Pvt. Ltd. India, and distributor Amneal Pharmaceuticals LLC Bridgewater, NJ. The NDC 69238-1473-3 and barcode are visible.*

FDA Label Image

Erythromycin Delayed Release Tablets Usp 7

Label for Erythromycin Delayed-Release Tablets, USP, 500 mg strength, oral dosage form. The label shows the product name prominently with strength in a green box. It indicates the quantity as 100 tablets and states Rx only. Manufacturer is Amneal Pharmaceuticals Pvt. Ltd., India, and distributor is Amneal Pharmaceuticals LLC, Bridgewater, NJ. Storage instructions and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.